Stock News - Moleculin Biotech, Inc. $MBRX
Latest Stock News for $MBRX
Moleculin Biotech Enrolls 45th Subject in Pivotal AML Trial, Data Readout Expected Mid-2026
Expected Stock impact: Very Positive
2026-03-23 12:32:08
Moleculin Biotech, Inc. Files 8-K with Corporate Presentation and Financial Exhibits
Expected Stock impact: None Expected
2026-03-19 12:46:37
Moleculin Biotech Reports 2025 Financial Results and Anticipates Key Data Unblinding in MIRACLE Trial
Expected Stock impact: Noticeably Positive
2026-03-19 12:36:41
